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66Presentations to general practice before a cancer
diagnosis in Victoria: a cross-sectional survey
Karen Lacey1, James F Bishop1,2, Hannah L Cross1, Patty Chondros2, Georgios Lyratzopoulos3, Jon D Emery2Abstract
Objective: To assess variations in the number of general
practitioner visits preceding a cancer diagnosis, and in the lengthThe known Most patients diagnosed with cancer had initially
consulted a general practitioner about their symptoms.of the interval between the patient ﬁrst suspecting a problem
and their seeing a hospital specialist.
Design, setting and participants: Analysis of data provided to
the Cancer Patient Experience Survey (CPES; survey response
rate, 37.7%) by 1552 patients with one of 19 cancer types and
treated in one of ﬁve Victorian Comprehensive Cancer Centre
hospitals, 1 October 2012 e 30 April 2013.
Main outcome measures: The primary outcome was the
proportion of patients who had had three or more GP
1V
L
PDelayed diagnosis is associated with poorer patient experience
and possibly worse clinical outcomes.
The new The number of GP visits and the time from symptom
onset to seeing a hospital specialist were strongly inﬂuenced
by cancer type. For example, patients with pancreatic cancer or
multiple myelomawere more likely to have visited a GP several
times; breast cancer patients were least likely to have done so.
The implications Strategies for reducing missed opportunities
for diagnosing cancer earlier in general practice are needed.consultations about cancer-related health problems before
being referred to hospital. The secondary outcome was the
interval between the patient ﬁrst suspecting a problem and their
seeing a hospital specialist.
Results: 34% of the patients included in the ﬁnal analyses
ancer is the leading cause of disease burden in Australia;1
by 2020 about 150 000 new cases will be diagnosed each
(426 of 1248) had visited a GP at least three times before referral
to a hospital doctor. The odds ratios (reference: rectal cancer;
adjusted for age, sex, language spoken at home, and socio-
economic disadvantage index score) varied according to cancer
type, being highest for pancreatic cancer (3.2; 95% CI, 1.02e9.9),
thyroid cancer (2.5; 95% CI, 0.9e6.6), vulval cancer (2.5;
95% CI, 0.7e8.7) and multiple myeloma (2.4; 95% CI, 1.1e5.5),
and lowest for patients with breast cancer (0.4; 95% CI,
0.2e0.8), cervical cancer (0.5; 95% CI, 0.1e2.1), endometrial
cancer (0.5; 95% CI, 0.2e1.4) or melanoma (0.7; 95% CI,
0.3e1.5). Cancer type also affected the duration of the interval
from symptom onset to seeing a hospital doctor; it took at least
3 months for more than one-third of patients with prostate or
colon cancer to see a hospital doctor.
Conclusion: Certain cancer types were more frequently
associated with multiple GP visits, suggesting they are more
challenging to recognise early. In Victoria, longer intervals from
the ﬁrst symptoms to seeing a hospital doctor for colon or
prostate cancer may reﬂect poorer community symptom
awareness, later GP referral, or limited access to
gastroenterology and urology services.Cyear.2 Most patients diagnosed with cancer had initially
consulted a general practitioner about their symptoms;3-6 GPs are
therefore pivotal in the timely diagnosis of cancer. A systematic
review found evidence that longer time to diagnosis is associated
with poorer clinical outcomes.7 Delays before cancer diagnosis
may be caused by various factors at the patient, general practice
and health system levels.8
Patients place great value in having their cancer symptoms recog-
nised early, a priority highlighted by a number of medico-legal
claims against GPs about perceived delays.9,10 Multiple pre-
diagnostic consultations with a GP are associated with a more
negative patient experience of subsequent cancer-related care.11
The 2010 English Cancer Patient Experience Survey (CPES)
examined GP visits preceding a cancer diagnosis, and found large
variations between cancer types.12 International research has
found that patient characteristics associated with primary care
delays include younger age, female sex, belonging to an ethnic
minority, and living in a rural area.5 However, there are few data
about GP consultations and factors associated with the amount of
time preceding a cancer diagnosis in Australia.
Our primary aim was to therefore assess the socio-demographic
and clinical factors associated with multiple GP visits by patients
subsequently diagnosed with cancer in Victoria. Our secondary
aim was to investigate factors associated with the length of the
interval between patients ﬁrst recognising a symptom and their
seeing a hospital doctor.Methods
Study design and setting
We undertook a cross-sectional survey in 2013 of patients treated
for cancer in ﬁve of the member hospitals of the Victorian
Comprehensive Cancer Centre (VCCC) that cover the inner cityictorian Comprehensive Cancer Centre, Melbourne, VIC. 2University of Melbourne, Melbo
ondon, London, United Kingdom. hannah.cross@unimelb.edu.au j doi: 10.5694/mja15
odcast with Professor Jon Emery is available at www.mja.com.au/multimedia/podcastsand western suburbs of Melbourne (Peter MacCallum Cancer,
MelbourneHealth, RoyalWomen’sHospital, St Vincent’sHospital
and Western Health).Data collection
The study design was based on the English CPES.12,13 The CPES
survey instrumentwas selected as it was cognitively validated and
ﬁeld-tested, and provided opportunities for international com-
parisons. The postal survey, provided in English, included 76
items, of which 65 assessed patient experience of diagnosis and
subsequent care. Responses were closed, with most based on
ordinal scales. In this article we report the results for two items
about experiences prior to hospital referral (Box 1). A dataurne, VIC. 3Cancer Research UK Health Behaviour Research Centre, University College
.01169
1 Outcome questions and response options in the 2013
Victorian Comprehensive Cancer Centre (VCCC) Cancer
Patient Experience Survey of patients with discharge dates,
October 2012 e April 2013*
Question 1: Before you were told you needed to go to hospital about
cancer, how many times did you see your GP (family doctor) about
the health problem caused by cancer?
1. None — I did not see my GP before going to hospital
2. I saw my GP once
3. I saw my GP twice
4. I saw my GP 3 or 4 times
5. I saw my GP 5 or more times
6. Don’t know/can’t say
Question 2: How long was it from the time you ﬁrst thought
something might be wrong with you until you ﬁrst saw a hospital
doctor?
1. Less than 3 months
2. 3e6 months
3. 6e12 months
4. More than 12 months
5. Don’t know/can’t remember
*These questions are identical to those used in the National Health Service (UK)
Cancer Patient Experience Survey.13u
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67management error at one of the health services meant that patients
who had declined to participate or had died could not be tracked.
The expert committee therefore decided to not send reminder let-
ters from that health service, so that only 25%of all non-responders
were sent a reminder.
Eligibility
Patients were eligible to participate if they were aged 18 years or
more, were discharged between 1 October 2012 and 30 April 2013
from one of the ﬁve VCCC hospitals, and had a conﬁrmed diag-
nosis of cancer in the primary diagnosis ﬁeld of their hospital re-
cord (International Classiﬁcation of Diseases, revision 10 [ICD-10]
codes C00eC99, excluding C44 [non-melanoma skin cancer];
Appendix 1). Our analysis included patients who had had at least
one GP consultation about symptoms related to their subsequent
cancer diagnosis. Patients were excluded if they had been diag-
nosed by a national screening program, hadpresented to a hospital
emergency department, or had been admitted to hospital for an
unrelated medical condition.12,13
Outcomes
The primary outcomewas the proportion of patients who had had
three or more GP consultations before referral to a hospital
specialist for suspected cancer (Box 1, question 1). The secondary
outcome was the length of the interval ( 3 months v < 3 months)
between patients suspecting a problemuntil the time theyﬁrst saw
a hospital doctor, whether a specialist in a private facility or at a
VCCC hospital (Box 1, question 2).
Explanatory variables
Analysis was restricted to the cancer types deﬁned by ICD-10
codes used for the analysis of CPES survey data in England.12
Non-Hodgkin and Hodgkin lymphoma diagnoses were
pooled, as were stomach and oesophageal cancer diagnoses,
because of the small numbers of the individual cancer types in our
sample.
Age was categorised as 18e34, 35e44, 45e54, 55e64, 65e74,
and 75 years. The age groups 18e24 and 25e34 years and 75e84and 85 years were each aggregated because of the small number
of participants in these categories. Sex was determined from
hospital records.
Socio-economic status was assessed according to the Australian
Bureau of Statistics’ Index of Relative Socio-economic Disadvan-
tage (IRSD) data for the patient’s residential postcode.14Statistical analysis
The number of GP visits prior to hospital referral about cancer and
the time to hospital referral, according to the participant’s age
group, sex, postcode IRSD, preferred language at home, and type
of cancer, were summarised as counts and percentages. Logistic
regression with robust standard errors was used to estimate odds
ratios (ORs) with 95% conﬁdence intervals for the primary and
secondary outcomes with respect to each explanatory variable.
AdjustedORs (aORs)were estimated using amultivariable logistic
model with robust standard errors. Sample sizes for the multi-
variable analyses were reduced because of missing responses for
language spoken at home and postcode IRSD. Rectal cancer was
used as the reference category to enable comparisons with the
EnglishCPES; it had beenused as the reference in the English study
because it was common in both sexes. We did not examine in-
teractions between socio-demographic variables and cancer type
because the sample size was too small. Stata 13.1 (StataCorp) was
used for all analyses.Ethics approval
Human research ethics committees at the PeterMacCallumCancer
Centre (reference, 13/11L),MelbourneHealth (QA2013016), Royal
Women’s Hospital (approved as Quality Assurance), St Vincent’s
Hospital (QA 014/13) andWesternHealth (QA2013016) approved
the study.Results
A total of 5772 potentially eligible patients were identiﬁed from
hospital records of the participating hospitals, of whom 4995 had a
conﬁrmed ICD-10 code for an eligible cancer diagnosis; 1885 of
these patients (37.7%) returned a survey, of which ﬁve with a
mismatch for age, sex or diagnosis code were excluded. Of the
remaining 1880 patients, 1552 had one of the 19 cancer types
included in our analysis; the patients ranged in age from 20 to
95 years.
Forty-nine of the 1552 patients (3.2%) did not respond to the
question about the number of visits to a GP before referral to
hospital about cancer; 1256 (83.6%) stated that they had seen a GP
at least once before they were referred to a hospital doctor. Five
patients with testicular cancer and three patients with mesotheli-
oma had visited a GP at least once before referral, but were
excluded from further analysis because of the small numbers for
these cancer types. About one-third of the remaining patients (426
of 1248; 34.1%) had visited a GP at least three times before being
referred to a hospital doctor.
Of the 1248 respondents who had seen a GP at least once before a
hospital referral, 37 (3%) did not respond to the question about the
length of time before seeing a hospital doctor, and were therefore
excluded from this particular analysis. Of the 1211 patients who
responded to this question, 260 (21.5%) stated that at least 3months
had elapsed between ﬁrst noticing that something was wrong and
seeing a hospital doctor.
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68Number of GP visits
There were large variations in the proportions of patients
with particular cancer types who visited their GP at least
three times before referral (Box 2; Appendix 2, Figure 1). In
the adjusted analysis, the odds of at least three GP visits
before referral were signiﬁcantly inﬂuenced by tumour type.
In the adjusted analysis, patients with breast cancer (aOR, 0.4;
95% CI, 0.2e0.8) were least likely to have had three or more
GP visits before referral to hospital; patients with pancreatic2 Odds ratios (with 95% conﬁdence intervals) for patients (n¼ 1
problems three or more times (v fewer than three times) befo
Total number 3 GP visits Crude odds ra
Sex
Men 654 261 (39.9%) 1
Women 594 165 (27.8%) 0.58
Age (years)
18e34 41 12 (29.3%) 0.85
35e44 91 32 (35.2%) 1.11
45e54 185 50 (27.0%) 0.76
55e64 321 117 (36.4%) 1.17
65e74 399 131 (32.8%) 1
 75 211 84 (39.8%) 1.35
Language spoken at home (missing responses: 51)
English 1042 335 (32.1%) 1
Other 155 66 (42.6%) 1.57
Index of Relative Socio-economic Disadvantage, by quartiles (missing res
4 (least disadvantaged) 389 117 (30.1%) 1
3 374 133 (35.6%) 1.28
2 294 102 (34.7%) 1.24
1 (most disadvantaged) 184 72 (39.1%) 1.49
Type of cancer
Pancreatic 18 11 (61%) 3.98
Thyroid 31 15 (48%) 2.38
Vulval 12 6 (50%) 2.53
Multiple myeloma 59 29 (49%) 2.45
Brain 14 8 (57%) 3.38
Prostate 159 73 (46%) 2.15
Lymphoma 128 54 (42%) 1.85
Leukaemia 82 32 (39%) 1.62
Lung 107 42 (39%) 1.64
Colon 47 20 (43%) 1.88
Oesophageal/stomach 23 10 (43%) 1.95
Renal/bladder 64 25 (39%) 1.62
Ovarian 23 8 (35%) 1.35
Rectal (reference) 53 15 (28%) 1
Laryngeal 16 4 (25%) 0.84
Melanoma 129 29 (23%) 0.73
Endometrial 53 10 (19%) 0.59
Cervical 15 3 (20%) 0.63
Breast 215 32 (15%) 0.44
*Calculated using theWald test for categorical variables. †Adjusted odds ratio estimated
records were excluded because of missing responses for language spoken at home andcancer (aOR, 3.2; 95% CI, 1.02e9.9) or multiple myeloma
(aOR, 2.4; 95% CI, 1.1e5.5) were most likely to have visited
their GP at least three times before referral. In the unadjusted
analyses, the odds of at least three GP visits before referral
were signiﬁcantly inﬂuenced by sex, age group, and language
spoken at home, but the association with sex was lost after
adjusting for age group, language spoken at home, socio-
economic disadvantage index score of patient residence, and
type of cancer (Box 2).248) seeing a general practitioner about cancer-related health
re being advised to visit a hospital
tio 95% CI P* Adjusted odds ratioy 95% CI P*
<0.001 0.97
1
0.46e0.73 0.99 0.71e1.39
0.01 0.23
0.42e1.71 0.98 0.46e2.09
0.69e1.79 1.56 0.90e2.69
0.52e1.11 1.25 0.81e1.92
0.86e1.60 1.35 0.96e1.88
1
0.96e1.91 1.51 1.03e2.22
0.01 0.08
1
1.11e2.21 1.42 0.96e2.10
ponses: 7) 0.15 0.45
1
0.95e1.74 1.20 0.86e1.66
0.89e1.71 1.23 0.87e1.73
1.04e2.16 1.36 0.90e2.06
0.06 < 0.001
1.30e12.2 3.17 1.02e9.90
0.94e5.98 2.48 0.94e6.57
0.70e9.11 2.47 0.70e8.71
1.12e5.38 2.41 1.06e5.47
1.00e11.4 2.32 0.62e8.64
1.10e4.22 2.15 1.05e4.39
0.92e3.70 1.76 0.85e3.65
0.77e3.41 1.59 0.73e3.47
0.80e3.34 1.56 0.74e3.30
0.82e4.31 1.45 0.61e3.46
0.70e5.40 1.34 0.46e3.97
0.74e3.55 1.31 0.58e2.96
0.47e3.85 1.28 0.42e3.88
1
0.23e3.04 0.90 0.24e3.41
0.36e1.52 0.69 0.32e1.47
0.24e1.47 0.54 0.21e1.40
0.16e2.57 0.45 0.10e2.06
0.22e0.90 0.39 0.18e0.84
bymultivariable logistic regression, adjusted for all other variable categories; 58 patient
socio-economic disadvantage index.u
ResearchTime to assessment by hospital doctor
Box 3 and Appendix 2, Figure 2 summarise the odds of an interval
of at least 3 months elapsing between the patient ﬁrst suspecting a
problem and their ﬁrst seeing a hospital doctor, according to
tumour type andpatient characteristics. In theunadjusted analysis,
tumour type and sex were the only factors that signiﬁcantly
inﬂuenced the odds for this outcome. After adjustment for age,3 Odds ratios (with 95% conﬁdence intervals) for an interval of
patients suspecting a problem and their seeing a hospital doc
Total number 3 months Crude odds ra
Sex
Men 635 165 (26.0%) 1
Women 576 95 (16.5%) 0.56
Age, years
18e34 41 10 (24%) 1.12
35e44 88 15 (17%) 0.71
45e54 182 35 (19%) 0.83
55e64 307 67 (22%) 0.97
65e74 389 87 (22%) 1
 75 204 46 (23%) 1.01
Language spoken at home (missing responses: 48)
English 1013 212 (20.9%) 1
Other 150 35 (23.3%) 1.15
Index of Relative Socio-economic Disadvantage, by quartiles (missing res
4 (least disadvantaged) 379 82 (22%) 1
3 361 75 (21%) 0.95
2 287 59 (21%) 0.94
1 (most disadvantaged) 177 41 (23%) 1.09
Type of cancer
Colon 46 16 (35%) 1.45
Prostate 152 53 (35%) 1.45
Vulval 11 3 (27%) 1.02
Endometrial 52 13 (25%) 0.90
Lymphoma 126 36 (29%) 1.09
Laryngeal 16 4 (25%) 0.90
Renal/Bladder 63 17 (27%) 1.00
Rectal 52 14 (27%) 1
Cervical 15 3 (20%) 0.68
Multiple myeloma 57 13 (23%) 0.80
Ovarian 22 4 (18%) 0.60
Melanoma 127 23 (18%) 0.60
Pancreatic 18 3 (17%) 0.54
Brain 13 2 (15%) 0.49
Leukaemia 76 12 (16%) 0.51
Oesophageal/stomach 22 5 (23%) 0.80
Lung 106 16 (15%) 0.48
Thyroid 28 3 (11%) 0.33
Breast 209 20 (10%) 0.29
*Calculated using the Wald test for categorical variables. †Adjusted odds ratio estimated
patient records were excluded because of missing responses for language spoken at homlanguage spoken at home, socio-economic disadvantage index
score of patient residence, and tumour type, the association with
sexwas no longer signiﬁcant. Consistent with our data onmultiple
GP visits, intervals of 3 months or more were least likely for pa-
tients with breast cancer. In contrast, more than one-third of pa-
tients with prostate or colon cancer ﬁrst saw a hospital doctor after
3 months or more.at least 3 months (v less than 3 months) elapsing between
tor
tio 95% CI P* Adjusted odds ratioy 95% CI P*
<0.001 0.19
1
0.42e0.75 0.77 0.51e1.14
0.83 0.76
0.53e2.38 1.37 0.60e3.13
0.39e1.31 1.22 0.62e2.40
0.53e1.28 1.44 0.88e2.34
0.68e1.39 1.03 0.70e1.52
1
0.67e1.52 1.08 0.71e1.66
0.50 0.73
1
0.76e1.73 1.08 0.70e1.68
ponses: 7) 0.91 0.98
1
0.67e1.35 0.97 0.67e1.42
0.64e1.37 1.00 0.67e1.48
0.71e1.67 1.08 0.68e1.73
<0.001 0.001
0.61e3.43 1.55 0.64e3.78
0.72e2.92 1.52 0.73e3.16
0.24e4.39 1.30 0.29e5.77
0.38e2.18 1.15 0.45e2.93
0.53e2.24 1.11 0.52e2.39
0.25e3.28 1.01 0.27e3.78
0.44e2.30 1.01 0.42e2.38
1
0.17e2.77 0.93 0.20e4.22
0.34e1.92 0.89 0.36e2.17
0.17e2.10 0.74 0.20e2.72
0.28e1.29 0.61 0.28e1.35
0.14e2.17 0.59 0.15e2.34
0.10e2.51 0.53 0.11e2.67
0.21e1.21 0.49 0.20e1.21
0.25e2.57 0.48 0.12e1.91
0.21e1.09 0.45 0.19e1.07
0.08e1.25 0.35 0.09e1.36
0.13e0.62 0.33 0.14e0.76
by multivariable logistic regression, adjusted for all the variables shown in the box; 55
e and socio-economic disadvantage index.u
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70Discussion
This is the ﬁrst study to report Australian CPES-based data on
patient experiences prior to referral to hospital about cancer.
Cancer type was a strong predictor of the number of GP visits and
the time from symptom onset (as judged by the patient) to ﬁrst
seeing a hospital specialist. Patients with myeloma or pancreatic
cancer were more likely to visit a GP several times before being
referred to a hospital specialist, and the interval between symptom
onset and seeing a hospital specialist was more likely to be at least
3 months for people with colon or prostate cancer. Women with
breast cancerwere less likely to visit aGP three times before referral
or to have an interval of at least 3 months between symptom onset
and seeing a hospital specialist. Our ﬁndings, particularly those
related to GP visits, are consistent with data from the English
CPES.12Major ﬁndings
Our data on multiple GP visits by patients with speciﬁc cancer
types suggest that certain cancers are inherently more difﬁcult to
detect in primary care, in line with earlier research and data from
the English CPES.9,12,15 Pancreatic cancer and multiple myeloma
present diagnostic challenges in primary care because of their non-
speciﬁc symptoms and the limited availability of easy-to-use tests
for early detection.16,17 With the exception of jaundice, which is a
presenting symptom in only very few cases, the positive predictive
value of other common symptoms of pancreatic cancer is very
low.18 In contrast, symptoms of and diagnostic tests for breast
cancer are more speciﬁc, so that it is less likely that multiple GP
visits occur before referral.
Compared with the data from the English CPES,12 a higher pro-
portion of Australian patients had three or more GP consultations
before they were referred to a hospital specialist (34% v 23%). This
may reﬂect differences between Australian and English GPs in
thresholds for referring patients suspected to have cancer, espe-
cially given the signiﬁcant and sustained focus on early cancer
diagnosis in England over the past decade. Alternatively, differ-
ential access to diagnostic tests may underlie this ﬁnding. Direct
access to key diagnostic tests is restricted for GPs in England,
whereas Australian GPs have good access to various types of
investigation, particularly radiology and pathology.4 In-
vestigations in primary care are associated with later referrals to a
specialist,19 as communicating the results and organising the
referral may require additional consultations.
For about one-ﬁfth of patients, more than 3 months elapsed be-
tween feeling that something was wrong and seeing a hospital
doctor. This interval can be affected by several patient-, GP- and
health system-related factors.8 Patients may take longer to present
with certain symptoms; it may take several visits for a GP to
recognise a potential cancer diagnosis and to refer the patient to a
specialist; waiting times can be longer for some hospital specialists.
In Australia, the mixture of public and private health care pro-
viders is complex, and we could not identify whether the period
before seeing a specialist was longer for patients referred to public
hospitals.
Althoughpancreatic andbrain cancersweremore likely thanmany
cancer types to be associated with several GP consultations
before referral to hospital, the overall process to seeing a specialist
was less likely to take 3 months or more. This may be because of
clearer and more rapid referral pathways for patients with these
cancer types. The period before seeing a hospital specialist was
more likely to be at least 3 months for individuals with prostate orcolon cancer, possibly because patients or GPs erroneously attri-
bute symptoms to more common, benign conditions;8 alterna-
tively, limited access to gastroenterologists or urologists may be
important.20,21
Ourdata indicate that breast cancer patientswere less likely tohave
made three ormoreGPvisits or for 3months to have elapsedbefore
seeing a hospital doctor. At the patient level, this probably repre-
sents greater community awareness of breast cancer symptoms. In
general practice, breast cancer symptoms are more speciﬁc and
more likely to be recognised, so that patients are referred more
promptly. There are also clearer diagnostic pathways for women
with suspected breast cancer.Limitations
There are limitations to this study related to the challenges of
conducting large scale surveys of patients recently diagnosed
with cancer. The response rate to the invitation to participate in
the CPES was only 38%. The VCCC had expected a response rate
of 35%, in line with other Australian patient experience surveys,
including the Australia CANnet Consumer Survey Question-
naire (29%) and the Victoria PROSPECT Cancer Critical Care
Events survey (46%). Response may have also been affected by
the low rate (25%) of reminder letters. The VCCC CPES was only
provided to patients by mail-out (ie, no electronic version), and
the survey was available only in English. Further, our sample
was smaller than the sample size for the English CPES, so that
the conﬁdence intervals for our data were broader.
Therewas a delay of a fewmonths between hospital discharge and
the invitation to participate in the study, potentially introducing
both recall and survival bias, as patients who died soon after
diagnosis were not surveyed. Although we proﬁled the pre-
hospital experiences of patients with 19 different cancer type di-
agnoses, sample limitations precluded the examination of other,
rarer cancers.15
Non-response bias could not be assessed, and non-responders
may have had different pre-hospital experiences, although this
is of greater concern for overall mean estimates than for patterns
of variation.Our study only assessed variations in patterns of care
for people with a known cancer diagnosis. We do not have
comparative data on referrals where a GP suspected cancer in
someone who eventually received an alternative diagnosis. It is
possible that some patients referred by the GP for suspected
cancer may have initially visited a private facility, where their
cancer was diagnosed before they underwent treatment in a
VCCC hospital. Participants were asked in this survey about the
length of time before ﬁrst seeing a hospital doctor as a key part
of their pre-diagnostic pathway and an important potential
contributor to diagnostic delay. We could not identify which
patientswere diagnosed in aVCCChospital or a private specialist
setting, or whether different cancer diagnostic pathways affected
the time between noting initial symptoms and seeing a hospital
specialist. The VCCC hospitals are all metropolitan, but treat
patients from across Victoria. Further investigations of the
potentially complex paths of patients between public and private
systems are required, and also of differences in the experiences of
metropolitan and rural patients.Conclusion
Our study provides an initial overview of the patterns of
consultation prior to referral to hospital for cancer in Victoria.
It shows that certain cancers are more likely to be associated
Researchwith multiple visits to a GP before the GP refers the patient to
hospital. While GPs must balance the risks of later diagnosis
against overinvestigation of patients who are unlikely to
have cancer, GPs may need to raise their level of suspicion
for symptoms suggestive of certain cancers.6 Our data suggest
that certain cancers may be more difﬁcult to diagnose because
their symptom signature is more complex.22 Earlier diagnosis
of these cancers may require different approaches to those
that have been successful for breast cancer. Strategies should
be investigated that reduce missed opportunities for diag-
nosing cancer earlier in general practice, including decisionsupport tools, fast track referral pathways, and signiﬁcant
event audit.
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